AI VIVO
Cambridge, United Kingdom
AI VIVO develops a unique systems pharmacology platform powered by AI to accelerate drug discovery. We believe biology, health and disease are all about balance and imbalance. Our platform provide a proprietary system-driven methodology to represent these imbalances using functional omics data and predict unexpected novel modulation strategies to restore the stability and alleviating pathological imbalance. This disruptive technology enables us to speed up the whole drug discovery process by identify promising candidates, de-risk the opportunities through preclinical validations, and progress drug candidates to the clinic through industry and investor partnerships.
Company Info
- Founded
- 2017
- Website
- aivivo.co/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of AI VIVO?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.